DJIA 18,214.42 -10.15 -0.06%
NASDAQ 4,987.89 20.75 0.42%
S&P 500 2,110.74 -3.12 -0.15%
market minute promo

TESARO (NASDAQ: TSRO)



company name or ticker

Is Biotech in a Bubble? The Bear Case Explained

Biotech IPOs provide some powerful indications...

Why 2014 May Be a Big Year for Opko Health, Inc.

Opko's (OPK) has a number of catalysts this year that could have a big impact on its biggest investor, Philip Frost; including a Tesaro's (TSRO) potential FDA filing for Rolapitant.

Myriad Genetics Inks HRD Alliance with Tesaro - Analyst Blog

3 Stocks to Get on Your Watchlist

SodaStream, Cisco, and Opko Health are this week's must-watch stocks.

Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal

Five Prime, Bristol-Myers Squibb cut $350M immuno-oncology deal.

Did Tesaro Just Enter Yet Another Overcrowded Space?

Should You Believe Tesaro's Hype?

A new license for promising technology from AnaptysBio could eventually help increase the number of drugs in Tesaro's (TSRO) pipeline.

Are We in the Midst of Irrational Exuberance Version 2.0?

It's been 17 years since former Fed chief Alan Greenspan coined the term irrational exuberance, but frothy valuations are once again making the market look top-heavy.

This Week in Biotech: NW Bio Soars While Geron Goes Geronimo

Two early-stage study results, a rare hospital exemption approval in Germany, and a devastating full clinical hold for one biotech are among this week's top biotech stories.

TESARO's CEO Presents at Immuno-Oncology License Agreement & Collaboration Conference (Transcript)

See More Articles...